{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:06:22Z","timestamp":1784732782326,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"DOI":"10.7759\/cureus.113158","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:41:10Z","timestamp":1784731270000},"source":"Crossref","is-referenced-by-count":0,"title":["Advances in Positron Emission Tomography Combined With Computed Tomography (PET\/CT) Imaging in Cervical Cancer: From Metabolic Assessment to Fibroblast Activation Protein-Targeted Imaging"],"prefix":"10.7759","author":[{"given":"Sharjeel","family":"Usmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram A","family":"Burney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Kheruka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah P","family":"Numani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cervical cancer. (2026). Accessed. 2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.180.6.1801621","article-title":"Diagnosis, staging, and surveillance of cervical carcinoma","volume":"180","author":"Kaur H","year":"2003","unstructured":"Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol. 2003, 180:1621-31. 10.2214\/ajr.180.6.1801621","journal-title":"AJR Am J Roentgenol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0088-7","article-title":"Pretreatment staging of cervical cancer: is imaging better than palpation?","volume":"15","author":"Hancke K","year":"2008","unstructured":"Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C. Pretreatment staging of cervical cancer: is imaging better than palpation?. Ann Surg Oncol. 2008, 15:2856-61. 10.1245\/s10434-008-0088-7","journal-title":"Ann Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170283","article-title":"The role of 18F-FDG PET CT in common gynaecological malignancies","volume":"90","author":"Narayanan P","year":"2017","unstructured":"Narayanan P, Sahdev A. The role of 18F-FDG PET CT in common gynaecological malignancies. Br J Radiol. 2017, 90:20170283. 10.1259\/bjr.20170283","journal-title":"Br J Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003707","article-title":"18F-FDG PET uptake in the scalp after platelet-rich plasma therapy","volume":"47","author":"Usmani S","year":"2022","unstructured":"Usmani S, Al-Turkait D, Al-Kandari F, Ahmed N. 18F-FDG PET uptake in the scalp after platelet-rich plasma therapy. Clin Nucl Med. 2022, 47:e43-4. 10.1097\/RLU.0000000000003707","journal-title":"Clin Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05653-0","article-title":"Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA","volume":"49","author":"Backhaus P","year":"2022","unstructured":"Backhaus P, Gierse F, Burg MC, et al.. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA. Eur J Nucl Med Mol Imaging. 2022, 49:1822-32. 10.1007\/s00259-021-05653-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000002132","article-title":"Radiolabeled fibroblast activation protein inhibitor PET\/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda","volume":"47","author":"Usmani S","year":"2026","unstructured":"Usmani S, Burney IA, Ahmed N, et al.. Radiolabeled fibroblast activation protein inhibitor PET\/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda. Nucl Med Commun. 2026, 47:612-20. 10.1097\/MNM.0000000000002132","journal-title":"Nucl Med Commun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl K","year":"2021","unstructured":"Dendl K, Koerber SA, Kratochwil C, et al.. FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?. Cancers (Basel). 2021, 13:4946. 10.3390\/cancers13194946","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mibio.2003.12.004","article-title":"Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer","volume":"6","author":"Wong TZ","year":"2004","unstructured":"Wong TZ, Jones EL, Coleman RE. Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol. 2004, 6:55-62. 10.1016\/j.mibio.2003.12.004","journal-title":"Mol Imaging Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31050188","article-title":"Impact of PET\/CT imaging with FDG in locally advanced cervical carcinoma-a literature review","volume":"31","author":"Molnar O","year":"2024","unstructured":"Molnar O, Straciuc OM, Mihu\u021biu S, Laz\u0103r L. Impact of PET\/CT imaging with FDG in locally advanced cervical carcinoma-a literature review. Curr Oncol. 2024, 31:2508-26. 10.3390\/curroncol31050188","journal-title":"Curr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70011-6","article-title":"Nodal-staging surgery for locally advanced cervical cancer in the era of PET","volume":"13","author":"Gouy S","year":"2012","unstructured":"Gouy S, Morice P, Narducci F, et al.. Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol. 2012, 13:e212-20. 10.1016\/S1470-2045(12)70011-6","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9830","article-title":"The role of PET\/CT in the management of cervical cancer","volume":"201","author":"Mirpour S","year":"2013","unstructured":"Mirpour S, Mhlanga JC, Logeswaran P, Russo G, Mercier G, Subramaniam RM. The role of PET\/CT in the management of cervical cancer. AJR Am J Roentgenol. 2013, 201:W192-205. 10.2214\/AJR.12.9830","journal-title":"AJR Am J Roentgenol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1515\/med-2018-0065","article-title":"Meta-analysis of PET\/CT detect lymph nodes metastases of cervical cancer","volume":"13","author":"Ruan J","year":"2018","unstructured":"Ruan J, Zhang Y, Ren H. Meta-analysis of PET\/CT detect lymph nodes metastases of cervical cancer. Open Med (Wars). 2018, 13:436-42. 10.1515\/med-2018-0065","journal-title":"Open Med (Wars)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000108","article-title":"Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma","volume":"29","author":"Lin A","year":"2019","unstructured":"Lin A, Ma S, Dehdashti F, et al.. Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma. Int J Gynecol Cancer. 2019, 29:487-91. 10.1136\/ijgc-2018-000108","journal-title":"Int J Gynecol Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017170963","article-title":"Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET\/CT: analysis from the ACRIN 6671\/GOG 0233 multicenter trial","volume":"287","author":"Gee MS","year":"2018","unstructured":"Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI. Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET\/CT: analysis from the ACRIN 6671\/GOG 0233 multicenter trial. Radiology. 2018, 287:176-84. 10.1148\/radiol.2017170963","journal-title":"Radiology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jimaging11020063","article-title":"Unraveling the role of PET in cervical cancer: review of current applications and future horizons","volume":"11","author":"Yadav D","year":"2025","unstructured":"Yadav D, O'Dwyer E, Agee M, Dutruel SP, Mahajan S, Huicochea Castellanos S. Unraveling the role of PET in cervical cancer: review of current applications and future horizons. J Imaging. 2025, 11:63. 10.3390\/jimaging11020063","journal-title":"J Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8874990","article-title":"Diagnostic accuracy of 18F-FDG-PET\/CT and MRI in predicting the tumor response in locally advanced cervical carcinoma treated by chemoradiotherapy: a meta-analysis","volume":"2021","author":"Sanei Sistani S","year":"2021","unstructured":"Sanei Sistani S, Parooie F, Salarzaei M. Diagnostic accuracy of 18F-FDG-PET\/CT and MRI in predicting the tumor response in locally advanced cervical carcinoma treated by chemoradiotherapy: a meta-analysis. Contrast Media Mol Imaging. 2021, 2021:8874990. 10.1155\/2021\/8874990","journal-title":"Contrast Media Mol Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.028","article-title":"Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer","volume":"112","author":"Brooks RA","year":"2009","unstructured":"Brooks RA, Rader JS, Dehdashti F, et al.. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009, 112:104-9. 10.1016\/j.ygyno.2008.08.028","journal-title":"Gynecol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2022-0042","article-title":"FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI","volume":"56","author":"Stojiljkovic M","year":"2022","unstructured":"Stojiljkovic M, Sobic Saranovic D, Odalovic S, et al.. FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI. Radiol Oncol. 2022, 56:453-60. 10.2478\/raon-2022-0042","journal-title":"Radiol Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.409","article-title":"The role of [18F]FDG-PET\/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy","volume":"8","author":"Lazzari R","year":"2014","unstructured":"Lazzari R, Cecconi A, Jereczek-Fossa BA, et al.. The role of [18F]FDG-PET\/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy. Ecancermedicalscience. 2014, 8:405. 10.3332\/ecancer.2014.409","journal-title":"Ecancermedicalscience"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05112-2","article-title":"EANM\/SNMMI practice guideline for [18F]FDG PET\/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0","volume":"48","author":"Adam JA","year":"2021","unstructured":"Adam JA, Loft A, Chargari C, et al.. EANM\/SNMMI practice guideline for [18F]FDG PET\/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0. Eur J Nucl Med Mol Imaging. 2021, 48:1188-99. 10.1007\/s00259-020-05112-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13121","article-title":"Cancer-associated fibroblasts as cellular vehicles in endometrial cancer cell migration","volume":"23","author":"Voon YC","year":"2022","unstructured":"Voon YC, Omar IS, Wu MH, Said NA, Chung I. Cancer-associated fibroblasts as cellular vehicles in endometrial cancer cell migration. Oncol Lett. 2022, 23:3. 10.3892\/ol.2021.13121","journal-title":"Oncol Lett"},{"key":"ref24","article-title":"Initial clinical experience using 68Ga-FAPI-46 PET\/CT for detecting various cancer types","volume":"27","author":"Dadgar H","year":"2024","unstructured":"Dadgar H, Norouzbeigi N, Assadi M, et al.. Initial clinical experience using 68Ga-FAPI-46 PET\/CT for detecting various cancer types. Hell J Nucl Med. 2024, 27:105-20.","journal-title":"Hell J Nucl Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl K","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, et al.. 68Ga-FAPI-PET\/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021, 48:4089-100. 10.1007\/s00259-021-05378-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153953","article-title":"Correlation between [68Ga]Ga-FAPI-46 PET imaging and HIF-1\u03b1 immunohistochemical analysis in cervical cancer: proof-of-concept","volume":"15","author":"Mokoala KM","year":"2023","unstructured":"Mokoala KM, Lawal IO, Maserumule LC, et al.. Correlation between [68Ga]Ga-FAPI-46 PET imaging and HIF-1\u03b1 immunohistochemical analysis in cervical cancer: proof-of-concept. Cancers (Basel). 2023, 15:3953. 10.3390\/cancers15153953","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004505","article-title":"First clinical experience with [68Ga]Ga-FAPI-46-PET\/CT versus [18F]F-FDG PET\/CT for nodal staging in cervical cancer","volume":"48","author":"Wegen S","year":"2023","unstructured":"Wegen S, Roth KS, Weindler J, et al.. First clinical experience with [68Ga]Ga-FAPI-46-PET\/CT versus [18F]F-FDG PET\/CT for nodal staging in cervical cancer. Clin Nucl Med. 2023, 48:150-5. 10.1097\/RLU.0000000000004505","journal-title":"Clin Nucl Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05146-6","article-title":"Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT","volume":"48","author":"Zhao L","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, et al.. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021, 48:1944-55. 10.1007\/s00259-020-05146-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref29","article-title":"Comparison of 68GA-FAPI-04 PET\/CT and 18F-FDG PET\/CT findings in peritonitis carcinomatosa cases","volume":"26","author":"G\u00fczel Y","year":"2023","unstructured":"G\u00fczel Y, Kaplan \u0130. Comparison of 68GA-FAPI-04 PET\/CT and 18F-FDG PET\/CT findings in peritonitis carcinomatosa cases. Hell J Nucl Med. 2023, 26:26-34.","journal-title":"Hell J Nucl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000001977","article-title":"The role of 68 Ga-FAPI PET\/CT imaging in gynecological cancers: an integrative review","volume":"46","author":"Usmani S","year":"2025","unstructured":"Usmani S, Al Riyami K, Ahmad N, Burney IA. The role of 68 Ga-FAPI PET\/CT imaging in gynecological cancers: an integrative review. Nucl Med Commun. 2025, 46:585-91. 10.1097\/MNM.0000000000001977","journal-title":"Nucl Med Commun"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004833","article-title":"Head-to-head comparison of 18 F-FDG and 68 Ga-FAPI-04 PET\/CT for radiological evaluation of cervical cancer","volume":"48","author":"Shu Q","year":"2023","unstructured":"Shu Q, He X, Chen X, Liu M, Chen Y, Cai L. Head-to-head comparison of 18 F-FDG and 68 Ga-FAPI-04 PET\/CT for radiological evaluation of cervical cancer. Clin Nucl Med. 2023, 48:928-32. 10.1097\/RLU.0000000000004833","journal-title":"Clin Nucl Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06539-z","article-title":"Comparison of the diagnostic value of [68\u00a0Ga]Ga-FAPI-04 PET\/MR and [18F]FDG PET\/CT in patients with T stage\u2009\u2264\u20092a2 uterine cervical cancer: a prospective study","volume":"51","author":"Lyu Y","year":"2024","unstructured":"Lyu Y, Chen X, Liu H, Xi Y, Feng W, Li B. Comparison of the diagnostic value of [68\u00a0Ga]Ga-FAPI-04 PET\/MR and [18F]FDG PET\/CT in patients with T stage\u2009\u2264\u20092a2 uterine cervical cancer: a prospective study. Eur J Nucl Med Mol Imaging. 2024, 51:1163-72. 10.1007\/s00259-023-06539-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01812","article-title":"68Ga\/177Lu-labeled theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention","volume":"67","author":"Huang J","year":"2024","unstructured":"Huang J, Zhang X, Liu Q, et al.. 68Ga\/177Lu-labeled theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention. J Med Chem. 2024, 67:17785-95. 10.1021\/acs.jmedchem.4c01812","journal-title":"J Med Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510582-advances-in-positron-emission-tomography-combined-with-computed-tomography-petct-imaging-in-cervical-cancer-from-metabolic-assessment-to-fibroblast-activation-protein-targeted-imaging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:41:12Z","timestamp":1784731272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510582-advances-in-positron-emission-tomography-combined-with-computed-tomography-petct-imaging-in-cervical-cancer-from-metabolic-assessment-to-fibroblast-activation-protein-targeted-imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.113158","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}